Top

Published in:

01-06-2004 | Commentary

The time has come to target connective tissue growth factor in diabetic complications

Authors: S. M. Twigg, M. E. Cooper

Published in: Diabetologia | Issue 6/2004

Excerpt

Dysregulation of growth factors is amongst the changes that occur in cells and tissues in diabetes. As growth factors commonly control essential biological functions, it follows that they may be critical in causing the end-organ complications of diabetes [1]. Consequently, identifying the key growth factor(s) that cause a particular type and stage of diabetic tissue damage is of potential importance in preventing and treating diabetes complications. …

Flyvbjerg A (2000) Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43:1205–1223

Brigstock DR (2003) The CCN family: a new stimulus package. J Endocrinol 178:169–175PubMed

Gore-Hyer E, Shegogue D, Markiewicz M et al. (2002) TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283:F707–F716PubMed

Dolan V, Hensey C, Brady HR (2003) Diabetic nephropathy: renal development gone awry? Pediatr Nephrol 18:75–84PubMed

Chen CC, Chen N, Lau LF (2001) The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276:10443–10452CrossRefPubMed

Shimo T, Nakanishi T, Nishida T et al. (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126:137–145PubMed

Murphy M, Godson C, Cannon S et al. (1999) Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274:5830–5834PubMed

Riser BL, Denichilo M, Cortes P et al. (2000) Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11:25–38PubMed

Wang S, Denichilo M, Brubaker C, Hirschberg R (2001) Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60:96–105PubMed

10.

Ito Y, Aten J, Bende RJ et al. (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853–861PubMed

11.

Candido R, Forbes JM, Thomas MC et al. (2003) A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 92:785–792

12.

Candido R, Jandeleit-Dahm KA, Cao Z et al. (2002) Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106:246–253CrossRefPubMed

13.

Tikellis C, Cooper ME, Twigg SM, Burns WC, Tolcos M (2004) Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by ACE inhibition. Endocrinology 145:860–866CrossRefPubMed

14.

Blom IE, Goldschmeding R, Leask A (2002) Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21:473–482CrossRefPubMed

15.

Twigg SM, Cao Z, McLennan SV et al. (2002) Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143:4907–4915CrossRefPubMed

16.

Ruperez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J, Ruiz-Ortega M (2003) Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circ Res 1081:499–505

17.

Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599–604

18.

Inoki I, Shiomi T, Hashimoto G et al. (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16:219–221PubMed

19.

Ziyadeh FN, Hoffman BB, Han DC et al. (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97:8015–8020PubMed

20.

Caldwell RB, Bartoli M, Behzadian MA et al. (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19:442–455CrossRefPubMed

21.

Twigg SM, Joly AH, Chen MM et al. (2002) Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 143:1260–1269CrossRefPubMed

22.

Lam SC, Geest RN van der, Verhagen NA et al. (2003) Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 52:2975–2983PubMed

23.

Abdel-Wahab N, Weston BS, Roberts T, Mason RM (2002) Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 13:2437–2445PubMed

24.

Gupta S, Clarkson MR, Duggan J, Brady HR (2000) Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389–1399CrossRef

25.

Goldschmeding R, Aten J, Ito Y, Blom IE, Rabelink T, Weening JJ (2000) Connective tissue growth factor: just another factor in renal fibrosis? Nephrol Dial Transplant 15:296–299CrossRefPubMed

26.

Ivkovic S, Yoon BS, Popoff SN et al. (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779–2791CrossRefPubMed

27.

Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N (2002) Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 16:963–974CrossRefPubMed

28.

Riser BL, Cortes P, DeNichilo M et al. (2003) Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int 64:451–458CrossRefPubMed

29.

Gilbert RE, Akdeniz A, Weitz S et al. (2003) Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care 26:2632–2636PubMed

30.

Adler SG, Kang SW, Feld S et al. (2002) Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria? Am J Kidney Dis 40:184–188CrossRefPubMed

Title: The time has come to target connective tissue growth factor in diabetic complications
Authors: S. M. Twigg
M. E. Cooper
Publication date: 01-06-2004
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 6/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-004-1423-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The time has come to target connective tissue growth factor in diabetic complications

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2004

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels

Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells

11β-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle

Identification of a new case of hepatocyte nuclear factor-1β mutation with highly varied phenotypes

Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page